Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Health Loss Due To Market Access Delays And Reimbursement Restrictions In First-Line EGFR-Positive Non-Small Cell Lung Cancer In The EU5 Countries
PaperCitations, authors & open-access status
Health Loss Due To Market Access Delays And Reimbursement Restrictions In First-Line EGFR-Positive Non-Small Cell Lung Cancer In The EU5 Countries is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 0 citations, 2017 year and closed oa status.
0
Citations
2017
Year
closed
OA Status